Clearmind Medicine Inc.
Clearmind develops novel psychedelic medicine based treatments to solve widespread, yet underserved health problems. With solid medical management and IP-protected treatments, the company aims to better the lives of millions of people.
Clearmind Medicine Inc. (CMND)
le 23 novembre/November 2023
Clearmind Medicine Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every thirty (30) pre-consolidated common shares.
As a result, the outstanding shares of the company will be reduced to approximately 607,381 common shares.
The name and symbol will not change.